Innate Pharma S.A. (IPHA)
NASDAQ: IPHA
· Real-Time Price · USD
2.23
0.04 (1.83%)
At close: Aug 18, 2025, 3:59 PM
Innate Pharma S.A. Income Statement
Financials in EUR. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Dec 31, 2024 | Jun 30, 2024 | Dec 31, 2023 | Jun 30, 2023 | Dec 31, 2022 | Jun 30, 2022 | Dec 31, 2021 | Jun 30, 2021 |
Revenue | 12.62M | 33.79M | 56.79M | 43.65M | 49.58M | 44.06M | 12.11M | 36.31M |
Cost of Revenue | n/a | 53.65M | 40.3M | 29.08M | 25.83M | 25.38M | 23.5M | 15.26M |
Gross Profit | 12.62M | -19.86M | 16.49M | 14.57M | 23.75M | 18.69M | -11.39M | 21.05M |
Operating Income | -51.58M | -38.58M | -17.52M | -34.06M | -24.63M | -26.73M | -57.48M | -43.99M |
Interest Income | 2.64M | 14.48M | 12.9M | 1.31M | 350K | 4K | 7.5K | 32K |
Pretax Income | -49.47M | -34.05M | -12.42M | -71.25M | -66.01M | -27.31M | -58.07M | -89.19M |
Net Income | -49.47M | -34.05M | -7.57M | -62.69M | -58.1M | -22.79M | -52.81M | -77.37M |
Selling & General & Admin | 11.93M | 18.73M | 17.69M | 18.11M | 20.94M | 16.88M | 18.89M | 29.44M |
Research & Development | 51.98M | 53.65M | 52.98M | 53.57M | 48.84M | 49.49M | 46.13M | 42.11M |
Other Expenses | 283K | -29.08M | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 64.2M | 17.64M | 45.01M | 71.68M | 69.78M | 66.37M | 65.02M | 71.55M |
Interest Expense | 634K | 3.62M | 3.35M | 418K | 94K | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | 338K | 245K | 148.5K | 265K | 326.5K | 196.5K | 222K |
Cost & Expenses | 64.2M | 71.28M | 73.22M | 77.71M | 74.21M | 70.79M | 69.59M | 80.3M |
Income Tax Expense | n/a | -9.75M | -14.6M | -8.62M | -8.04M | -11.93M | -12.59M | -11.82M |
Shares Outstanding (Basic) | 81.05M | 79.88M | 80.59M | 80.32M | 80.19M | 79.74M | 79.54M | 79M |
Shares Outstanding (Diluted) | 81.05M | 80.87M | 80.59M | 83.78M | 80.19M | 81.87M | 79.54M | 79M |
EPS (Basic) | -0.61 | -0.43 | -0.09 | -0.78 | -0.72 | -0.29 | -0.67 | -0.98 |
EPS (Diluted) | -0.61 | -0.43 | -0.09 | -0.78 | -0.72 | -0.29 | -0.67 | -0.98 |
EBITDA | -46.91M | -35.96M | -9.56M | -64.81M | -59.42M | -20.69M | -51.29M | -78.19M |
EBIT | -48.91M | -38.58M | -15.08M | -15.27M | -8.21M | -25.04M | -57.76M | -88.84M |
Depreciation & Amortization | 1.99M | 2.62M | 5.52M | 6.03M | 4.42M | 4.42M | 4.57M | 8.76M |